Can a video call replace a clinic visit for cancer patients on radiotherapy?
NCT ID NCT07724548
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether virtual follow-up visits are as good as in-person visits for cancer patients receiving radiotherapy. Researchers will compare patient and doctor satisfaction, communication quality, and how well telehealth works in a busy radiation oncology setting. The goal is to see if virtual visits can be a practical option during active cancer treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If virtual visits prove satisfactory and effective, this could support wider use of telehealth for cancer patients during treatment, reducing travel and wait times.
- What could go wrong
- This is a single-center trial with 180 participants, so results may not apply broadly. Telehealth may not suit all patients or detect certain clinical issues as well as in-person visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 180 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All cancer patients requiring radiotherapy
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients who are 18 years and above. 2. All patients who are undergoing radiotherapy (\>5 fractions). 3. Capacity to provide informed consent for participation in the study. Exclusion Criteria: 1. Patients below 18 years 2. Unable to provide informed consent for participation in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Radiotherapy are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Shaukat Khanum Memorial Cancer hospital & Research Centre
RECRUITINGLahore, Punjab Province, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Butter-Derived supplement protect the gut during cancer radiation?
- Can repeated MRI scans reveal how tumors respond to radiation?
- Can radiation before or after breast reconstruction improve outcomes?
- A sharper MRI could reveal radiation sensitivity of brain tumors
- Can adding radiation at the right time boost immunotherapy for aggressive lung cancer?
- Can a simple supplement soothe Radiation-Damaged rectums?